SMTL ID : 7tp2.1

Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; Subclassification D10 state

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

homo-trimer

Ligands

14 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 3 residues within 4Å: Chain A: T.108, N.232, T.234 No protein-ligand interaction detected (PLIP) NAG-NAG.2: 4 residues within 4Å: Chain A: N.715, L.920, Q.924, Q.1069 No protein-ligand interaction detected (PLIP) NAG-NAG.3: 3 residues within 4Å: Chain A: N.799, S.801, Q.802 No protein-ligand interaction detected (PLIP) NAG-NAG.4: 4 residues within 4Å: Chain A: N.1096, T.1098, H.1099, F.1101 No protein-ligand interaction detected (PLIP) NAG-NAG.5: 1 residues within 4Å: Chain A: N.1132 No protein-ligand interaction detected (PLIP) NAG-NAG.6: 2 residues within 4Å: Chain B: T.108, N.232 No protein-ligand interaction detected (PLIP) NAG-NAG.7: 3 residues within 4Å: Chain B: N.799, S.801, Q.802 No protein-ligand interaction detected (PLIP) NAG-NAG.8: 2 residues within 4Å: Chain B: I.1130, N.1132 No protein-ligand interaction detected (PLIP) NAG-NAG.9: 4 residues within 4Å: Chain B: N.715, L.920, Q.924, Q.1069 1 PLIP interactions: 1 interactions with chain B Hydrophobic interactions: B:L.920 NAG-NAG.10: 4 residues within 4Å: Chain B: N.1096, T.1098, H.1099, F.1101 No protein-ligand interaction detected (PLIP) NAG-NAG.11: 8 residues within 4Å: Chain B: S.457, N.458, K.460, E.463, Y.471 Chain C: T.108, N.232, T.234 No protein-ligand interaction detected (PLIP) NAG-NAG.12: 4 residues within 4Å: Chain C: N.1096, T.1098, H.1099, F.1101 No protein-ligand interaction detected (PLIP) NAG-NAG.13: 1 residues within 4Å: Chain C: N.1132 No protein-ligand interaction detected (PLIP) NAG-NAG.14: 3 residues within 4Å: Chain C: N.799, S.801, Q.802 No protein-ligand interaction detected (PLIP)

33 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.15: 2 residues within 4Å: Chain A: Y.28, N.61 Ligand excluded by PLIP NAG.16: 4 residues within 4Å: Chain A: N.122, T.124, N.125, V.169 Ligand excluded by PLIP NAG.17: 4 residues within 4Å: Chain A: N.278, E.279, N.280 Chain C: K.556 Ligand excluded by PLIP NAG.18: 4 residues within 4Å: Chain A: N.329, Q.578, T.579, L.580 Ligand excluded by PLIP NAG.19: 4 residues within 4Å: Chain A: G.337, F.340, N.341, L.366 Ligand excluded by PLIP NAG.20: 2 residues within 4Å: Chain A: N.601, T.602 Ligand excluded by PLIP NAG.21: 2 residues within 4Å: Chain A: N.614, T.616 Ligand excluded by PLIP NAG.22: 2 residues within 4Å: Chain A: H.653, N.655 Ligand excluded by PLIP NAG.23: 2 residues within 4Å: Chain A: N.707, G.1129 Ligand excluded by PLIP NAG.24: 1 residues within 4Å: Chain A: N.1072 Ligand excluded by PLIP NAG.25: 5 residues within 4Å: Chain A: Q.115, E.132, F.133, N.163, T.165 Ligand excluded by PLIP NAG.26: 3 residues within 4Å: Chain B: N.329, Q.578, T.579 Ligand excluded by PLIP NAG.27: 5 residues within 4Å: Chain B: F.336, G.337, F.340, N.341, L.366 Ligand excluded by PLIP NAG.28: 2 residues within 4Å: Chain B: N.601, T.602 Ligand excluded by PLIP NAG.29: 4 residues within 4Å: Chain B: Y.28, T.29, N.30, N.61 Ligand excluded by PLIP NAG.30: 1 residues within 4Å: Chain B: N.655 Ligand excluded by PLIP NAG.31: 6 residues within 4Å: Chain B: V.120, N.121, N.122, N.125, V.126, V.127 Ligand excluded by PLIP NAG.32: 3 residues within 4Å: Chain B: N.278, E.279, N.280 Ligand excluded by PLIP NAG.33: 3 residues within 4Å: Chain B: S.112, E.132, N.163 Ligand excluded by PLIP NAG.34: 3 residues within 4Å: Chain B: N.614, T.616, Q.642 Ligand excluded by PLIP NAG.35: 2 residues within 4Å: Chain B: N.707, G.1129 Ligand excluded by PLIP NAG.36: 2 residues within 4Å: Chain B: A.704, N.1072 Ligand excluded by PLIP NAG.37: 2 residues within 4Å: Chain C: Y.28, N.61 Ligand excluded by PLIP NAG.38: 3 residues within 4Å: Chain B: K.556 Chain C: E.279, N.280 Ligand excluded by PLIP NAG.39: 2 residues within 4Å: Chain C: N.329, Q.578 Ligand excluded by PLIP NAG.40: 2 residues within 4Å: Chain C: N.601, T.602 Ligand excluded by PLIP NAG.41: 1 residues within 4Å: Chain C: N.1072 Ligand excluded by PLIP NAG.42: 4 residues within 4Å: Chain C: F.336, G.337, F.340, N.341 Ligand excluded by PLIP NAG.43: 2 residues within 4Å: Chain C: N.614, T.616 Ligand excluded by PLIP NAG.44: 6 residues within 4Å: Chain C: S.112, K.113, E.132, F.133, Q.134, N.163 Ligand excluded by PLIP NAG.45: 1 residues within 4Å: Chain C: N.655 Ligand excluded by PLIP NAG.46: 3 residues within 4Å: Chain A: D.794 Chain C: N.707, G.1129 Ligand excluded by PLIP NAG.47: 4 residues within 4Å: Chain C: N.122, T.124, N.125, V.127 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gobeil, S.M. et al., Structural diversity of the SARS-CoV-2 Omicron spike. Mol.Cell (2022)

Release Date

2022-02-09

Peptides

Spike glycoprotein: ABC

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

Spike glycoprotein

Related Entries With Identical Sequence